Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study

ConditionAllogeneic Hematopoietic Stem Cell Transplantation

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorRuijin Hospital

About this trial

Clinical observational studies using epidemiologic theories and methods. Through the collection of various clinically relevant data, specific outcomes are evaluated in hematologic transplant patients, providing high quality real-world data for clinical practice, informing public health decision-making, and reducing the burden of disease

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

At least one visit to a stem cell transplant center beginning January 1, 2021

Proposed to undergo or have undergone hematopoietic stem cell transplantation

Disqualifiers

Long-term follow-up information for patients not available for any reason (e.g., unavailable or with serious concomitant disease) according to investigator opinion

Due to alcohol and drug addiction thus affecting their ability to follow the requirements of the study

Presence of conditions that could jeopardize patient safety or affect their adherence to the protocol, according to the investigator's opinion

Trial population

Patients who are proposed to undergo or have undergone allogeneic hematopoietic stem cell transplantation

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

Not listed

Trial groups

3,000 Participants

are grouped into 1 trial group

Group A: Cohort 1

Trial outcomes